Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Clinical trial NCT01727700 · COMPLETED
Trial details
- NCT number
- NCT01727700
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.